Johnson & Johnson

As baby powder concerns mounted, Johnson & Johnson focused marketing on minority, overweight women, report says

New Jersey jury clears Johnson & Johnson of liability in latest talc cancer trial

Johnson & Johnson receives federal subpoenas related to baby powder litigation

Quebec appeals court orders province to restore full coverage of rheumatoid-arthritis drug Remicade

Johnson & Johnson to buy robotics firm Auris Health

Johnson & Johnson misses estimates for 2019 sales forecast

Indian drug regulators take talcum powder samples from Johnson & Johnson facilities

Johnson and Johnson announces US$5-billion share buyback after shares extend losses

The Globe’s stars and dogs for the week

Johnson & Johnson shares tumble on report company knew of cancer-causing asbestos in baby powder

Jury clears Johnson & Johnson of liability in California talc cancer case

Johnson & Johnson offers to buy out Japan cosmetics firm Ci:z for $2.1-billion

Ontario to examine pharmaceutical firms' payments to doctors

Johnson & Johnson boosts outlook on strength in pharmaceutical business

Before the Bell: Big bank earnings dominate Wall Street; TSX futures edge higher

Before the Bell: Fresh trade fears knock futures; investors weigh Canada, U.S. jobs data